Paroxysmal Atrial Fibrillation in Elderly: Worldwide Preliminary Data of LINAC-Based Stereotactic Arrhythmia Radioablation Prospective Phase II Trial.

ABSTRACT: Treatment approach for elderly patients with atrial fibrillation (AF) is difficult. The present prospective phase-II trial evaluated LINAC-based stereotactic arrhythmia radioablation safety in this population. The reported data of the first 5 patients worldwide, showed no side effects, absence of AF episodes and without antiarrhythmic drugs.

Trial registration

ClinicalTrials.gov, identifier: NCT04575662.

SUBMITTER: Di Monaco A 

PROVIDER: S-EPMC8924125 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature